{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "iYTPGC9J544h"
      },
      "source": [
        "# 0.**Librerias**"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "solo para train, pero se pueden tomar de test tambien, cambiando el path"
      ],
      "metadata": {
        "id": "MCbHjQqy6U7_"
      }
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ModhXqzvtLcS",
        "outputId": "a5703150-1d95-4ca5-a906-7e83ddf4c74a"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "/content/cochrane_data\n",
            "\u001b[33mhint: Using 'master' as the name for the initial branch. This default branch name\u001b[m\n",
            "\u001b[33mhint: is subject to change. To configure the initial branch name to use in all\u001b[m\n",
            "\u001b[33mhint: of your new repositories, which will suppress this warning, call:\u001b[m\n",
            "\u001b[33mhint: \u001b[m\n",
            "\u001b[33mhint: \tgit config --global init.defaultBranch <name>\u001b[m\n",
            "\u001b[33mhint: \u001b[m\n",
            "\u001b[33mhint: Names commonly chosen instead of 'master' are 'main', 'trunk' and\u001b[m\n",
            "\u001b[33mhint: 'development'. The just-created branch can be renamed via this command:\u001b[m\n",
            "\u001b[33mhint: \u001b[m\n",
            "\u001b[33mhint: \tgit branch -m <name>\u001b[m\n",
            "Initialized empty Git repository in /content/cochrane_data/.git/\n",
            "Updating origin\n",
            "remote: Enumerating objects: 72074, done.\u001b[K\n",
            "remote: Counting objects: 100% (3/3), done.\u001b[K\n",
            "remote: Compressing objects: 100% (3/3), done.\u001b[K\n",
            "remote: Total 72074 (delta 0), reused 2 (delta 0), pack-reused 72071 (from 2)\u001b[K\n",
            "Receiving objects: 100% (72074/72074), 315.90 MiB | 12.84 MiB/s, done.\n",
            "Resolving deltas: 100% (2991/2991), done.\n",
            "From https://github.com/feliperussi/bridging-the-gap-in-health-literacy\n",
            " * [new branch]          felipe     -> origin/felipe\n",
            " * [new branch]          main       -> origin/main\n",
            "From https://github.com/feliperussi/bridging-the-gap-in-health-literacy\n",
            " * branch                main       -> FETCH_HEAD\n",
            "Updating files: 100% (47359/47359), done.\n"
          ]
        }
      ],
      "source": [
        "# 1. Crear carpeta y entrar\n",
        "!mkdir cochrane_data\n",
        "%cd cochrane_data\n",
        "\n",
        "# 2. Inicializar git vacÃ­o\n",
        "!git init\n",
        "\n",
        "# 3. Agregar remote\n",
        "!git remote add -f origin https://github.com/feliperussi/bridging-the-gap-in-health-literacy.git\n",
        "\n",
        "# 4. Activar modo sparse checkout\n",
        "!git config core.sparseCheckout true\n",
        "\n",
        "# 5. Indicar SOLO las carpetas que queremos\n",
        "!echo \"data_collection_and_processing/Data Sources/Cochrane/train/pls\" >> .git/info/sparse-checkout\n",
        "!echo \"data_collection_and_processing/Data Sources/Cochrane/train/non_pls\" >> .git/info/sparse-checkout\n",
        "\n",
        "# 6. Descargar solo esa parte del repo\n",
        "!git pull origin main\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 288
        },
        "id": "vKgnZOuavm74",
        "outputId": "90393a8e-8ff1-43ae-f3ca-4b5526a8934f"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "ðŸ“š Total PLS (sin accumulated): 4797\n",
            "ðŸ“‚ Total non-PLS (sin accumulated): 7251\n",
            "\n",
            "âœ… Emparejados 3426 pares por nombre base (sin 'accumulated' en ninguno)\n",
            "ðŸ’¾ Guardado en: cochrane_pairs_clean.csv\n"
          ]
        },
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "                          id                                file_pls  \\\n",
              "0  10.1002-14651858.CD000006  10.1002-14651858.CD000006.pub2-pls.txt   \n",
              "1  10.1002-14651858.CD000009  10.1002-14651858.CD000009.pub4-pls.txt   \n",
              "2  10.1002-14651858.CD000012  10.1002-14651858.CD000012.pub4-pls.txt   \n",
              "\n",
              "                                        file_non_pls  \\\n",
              "0        10.1002-14651858.CD000006.pub2-abstract.txt   \n",
              "1  10.1002-14651858.CD000009.pub4-abstract.txt_se...   \n",
              "2  10.1002-14651858.CD000012.pub4-abstract.txt_se...   \n",
              "\n",
              "                                                 pls  \\\n",
              "0  Absorbable stitches for repair of episiotomy a...   \n",
              "1  Do acupuncture and related therapies help smok...   \n",
              "2  Alternative versus conventional institutional ...   \n",
              "\n",
              "                                             non_pls  \n",
              "0  Background\\nApproximately 70% of women will ex...  \n",
              "1  We included 38 studies. Based on three studies...  \n",
              "2  Ten trials involving 11,795 women met the incl...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-2fc90961-96b9-4f93-96ac-1b0705538442\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>id</th>\n",
              "      <th>file_pls</th>\n",
              "      <th>file_non_pls</th>\n",
              "      <th>pls</th>\n",
              "      <th>non_pls</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>10.1002-14651858.CD000006</td>\n",
              "      <td>10.1002-14651858.CD000006.pub2-pls.txt</td>\n",
              "      <td>10.1002-14651858.CD000006.pub2-abstract.txt</td>\n",
              "      <td>Absorbable stitches for repair of episiotomy a...</td>\n",
              "      <td>Background\\nApproximately 70% of women will ex...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>10.1002-14651858.CD000009</td>\n",
              "      <td>10.1002-14651858.CD000009.pub4-pls.txt</td>\n",
              "      <td>10.1002-14651858.CD000009.pub4-abstract.txt_se...</td>\n",
              "      <td>Do acupuncture and related therapies help smok...</td>\n",
              "      <td>We included 38 studies. Based on three studies...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>10.1002-14651858.CD000012</td>\n",
              "      <td>10.1002-14651858.CD000012.pub4-pls.txt</td>\n",
              "      <td>10.1002-14651858.CD000012.pub4-abstract.txt_se...</td>\n",
              "      <td>Alternative versus conventional institutional ...</td>\n",
              "      <td>Ten trials involving 11,795 women met the incl...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2fc90961-96b9-4f93-96ac-1b0705538442')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-2fc90961-96b9-4f93-96ac-1b0705538442 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-2fc90961-96b9-4f93-96ac-1b0705538442');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "    <div id=\"df-42ada2c0-3b7b-4f81-9d4c-ffbba0c0e8ac\">\n",
              "      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-42ada2c0-3b7b-4f81-9d4c-ffbba0c0e8ac')\"\n",
              "                title=\"Suggest charts\"\n",
              "                style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "      </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "      <script>\n",
              "        async function quickchart(key) {\n",
              "          const quickchartButtonEl =\n",
              "            document.querySelector('#' + key + ' button');\n",
              "          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "          quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "          try {\n",
              "            const charts = await google.colab.kernel.invokeFunction(\n",
              "                'suggestCharts', [key], {});\n",
              "          } catch (error) {\n",
              "            console.error('Error during call to suggestCharts:', error);\n",
              "          }\n",
              "          quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "        }\n",
              "        (() => {\n",
              "          let quickchartButtonEl =\n",
              "            document.querySelector('#df-42ada2c0-3b7b-4f81-9d4c-ffbba0c0e8ac button');\n",
              "          quickchartButtonEl.style.display =\n",
              "            google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "        })();\n",
              "      </script>\n",
              "    </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "df",
              "summary": "{\n  \"name\": \"df\",\n  \"rows\": 3426,\n  \"fields\": [\n    {\n      \"column\": \"id\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3426,\n        \"samples\": [\n          \"10.1002-14651858.CD005124\",\n          \"10.1002-14651858.CD007843\",\n          \"10.1002-14651858.CD010298\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"file_pls\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3426,\n        \"samples\": [\n          \"10.1002-14651858.CD005124.pub2-pls.txt\",\n          \"10.1002-14651858.CD007843.pub4-pls.txt\",\n          \"10.1002-14651858.CD010298.pub2-pls.txt\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"file_non_pls\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3426,\n        \"samples\": [\n          \"10.1002-14651858.CD005124.pub2-abstract.txt\",\n          \"10.1002-14651858.CD007843.pub4-abstract.txt\",\n          \"10.1002-14651858.CD010298.pub2-abstract.txt\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"pls\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3426,\n        \"samples\": [\n          \"Antenatal psychosocial assessment for reducing perinatal mental health morbidity\\nWomen can develop mental health problems during pregnancy or at childbirth and over the following year. These problems range from depression (both minor and major), anxiety disorders, post\\u2010traumatic stress disorder to bipolar disorder, schizophrenia and psychosis (puerperal psychosis). Life stresses such as bereavement, separation, unemployment, illness, moving house, migration, lack of social support networks, a past history of psychological or psychiatric disorders, history of physical, emotional or sexual abuse, drug or alcohol abuse, dysfunctional personality or coping styles and parenting behaviours can contribute to their onset. Obstetric factors such as timing and type of delivery and infant temperament can also play a role. Disorders may become chronic and carry over to future pregnancies. The mother\\u2019s mood during pregnancy and mental illness can impact on the development of the baby both during pregnancy and after birth. Assessing women for psychosocial risk factors and symptoms of distress during regular pregnancy checks gives the opportunity to link women with appropriate services. \\nThe one study that met the criteria for this review randomised healthcare providers to either psychosocial assessment or routine care and involved a total of 273 women. The providers who assessed psychosocial factors were more likely than those giving routine care to identify psychosocial concerns and to rate the level of concern as high. They were also more likely to detect concerns about family violence. The trial did not look at the development of anxiety or depression in these women. Not all healthcare providers chose to take part in the trial and some dropped out, leaving only 48 of the original 185 approached. This could mean that providers who were less interested in this area of clinical practice did not participate and bias the findings toward better than average detection of psychosocial risk. Two studies are currently in progress looking at the impact of early postnatal psychosocial assessment on the prevalence of antenatal and postnatal anxiety and depression.\",\n          \"Blood transfusions for treating acute chest syndrome in people with sickle cell disease\\nReview question \\nWe reviewed the effectiveness of blood transfusions, for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care. This is an update of a Cochrane Review first published in 2010 and updated in 2016. \\nBackground \\nSickle cell disease (SCD) is an inherited blood condition affecting over 250 million people worldwide and is particularly common in Sub\\u2010Saharan Africa, South and Central America, Saudi Arabia, India and a number of Mediterranean countries. It is characterized by the presence of sickle\\u2010shaped red blood cells which are capable of blocking the blood vessels causing pain and severe damage to several organs of the body. People with SCD may have the acute onset of chest problems which may include fever, this is called acute chest syndrome. Treatment will depend on the individuals' clinical condition and the severity of the symptoms. Standard treatment consists of supportive care, antibiotics, intravenous fluids and blood transfusion, either simple or exchange, may also be indicated. \\nSearch date \\nThe evidence is current to: 30 May 2019.\\nKey results \\nOne study was included in the review, there were two parts to the study, one larger observational study and one randomised trial which was to assess transfusion versus standard care to prevent acute chest syndrome in people with sickle cell disease, while twenty\\u2010six centres were contracted. Only 10 participants were enrolled into the randomised trial. The effects of blood transfusions could not be determined from the trial; there were no data that could be presented or therefore analysed within this review for the very small number of participants enrolled. \\nTherefore, this unique study did not show how effective blood transfusions might be for treating acute chest syndrome in people with sickle cell disease. Future research is needed to provide evidence for people to make informed decisions on whether blood transfusions are effective for treating acute chest syndrome in people with sickle cell disease.\",\n          \"Janus kinase\\u20101 and Janus kinase\\u20102 inhibitors for treating myelofibrosis\\nReview question \\nWe reviewed the effects of Janus kinase\\u20101 and Janus kinase\\u20102 inhibitors for treating people with myelofibrosis. \\nBackground \\nMyelofibrosis is a disorder of the bone marrow in which the bone marrow is replaced by fibrous tissue. The symptoms depend on the degree of anemia and enlargement of the spleen. This condition has a poor prognosis and generally its treatment is palliative. \\nRuxolitinib is a drug in the class of Janus kinase inhibitors that tries to block the enzyme that derives in the scar tissue. \\nStudy characteristics \\nWe identified two clinical trials that included a limited number of patients comparing ruxolitinib to placebo or standard medical treatment. Both studies were published in 2012, and were conducted in the United States of America (USA) and the United Kingdom (UK). Drug companies sponsored both trials. \\nKey results \\nAlthough the results of the studies only showed a moderate improvement of patients treated with ruxolitinib in terms of their quality of life and a reduction in their spleen size, we could not be sure whether these effects were reliable because of the limitations of the studies and the low number of people they recruited. We also could not be sure whether the drug has an effect on overall survival compared with a placebo, or when it was compared with an active treatment. The effect of ruxolitinib in terms of progression\\u2010free survival was also uncertain. In addition, people treated with this drug showed higher rates of anemia, thrombocytopenia and neutropenia compared with patients treated with a placebo, but the rate of adverse effects was similar to those treated with a medical treatment. \\nQuality of evidence \\nThe confidence in the results of this review is very low. The studies have limitations in the way they were designed and executed. Moreover, the limited number of patients included in the studies led to imprecise results. Larger studies should provide more information about the effect of ruxolitinib. \\nResearchers from Cochrane searched all available literature up to 13 November 2014.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"non_pls\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3426,\n        \"samples\": [\n          \"Background\\nMental health conditions arising in the perinatal period, including depression, have the potential to impact negatively on not only the woman but also her partner, infant, and family. The capacity for routine, universal antenatal psychosocial assessment, and thus the potential for reduction of morbidity, is very significant. \\nObjectives\\nTo evaluate the impact of antenatal psychosocial assessment on perinatal mental health morbidity. \\nSearch methods\\nWe searched the Cochrane Pregnancy and Childbirth Group's Trials Register, the Cochrane Depression, Anxiety and Neurosis Group's Trials Register (CCDAN TR\\u2010Studies), HSRProj in the National Library of Medicine (USA), and the Current Controlled Trials website: http://www.controlled trials.com/ and the UK National Research Register (last searched March 2008). \\nSelection criteria\\nRandomised and quasi\\u2010randomised controlled trials.\\nData collection and analysis\\nAt least two review authors independently assessed trials for eligibility; they also extracted data from included trials and assessed the trials for potential bias. \\nMain results\\nTwo trials met criteria for an RCT of antenatal psychosocial assessment. One trial examined the impact of an antenatal tool (ALPHA) on clinician awareness of psychosocial risk, and the capacity of the antenatal ALPHA to predict women with elevated postnatal Edinburgh Depression Scale (EDS) scores, finding a trend towards increased clinician awareness of 'high level' psychosocial risk where the ALPHA intervention had been used (relative risk (RR) 4.61 95% confidence interval (CI) 0.99 to 21.39). No differences between groups were seen for numbers of women with antenatal EDS scores, a score of greater than 9 being identified by ALPHA as of concern for depression (RR 0.69 95% CI 0.35 to 1.38); 139 providers. The other trial reported no differences in EPS scores greater than 12 at 16 weeks postpartum between the intervention (communication about the EDS scores with the woman and her healthcare providers plus a patient information booklet) and the standard care groups (RR 0.86 95% CI 0.61 to 1.21; 371 women). \\nAuthors' conclusions\\nWhile the use of an antenatal psychosocial assessment may increase the clinician's awareness of psychosocial risk, neither of these small studies provides sufficient evidence that routine antenatal psychosocial assessment by itself leads to improved perinatal mental health outcomes. Further studies with better sample size and statistical power are required to further explore this important public health issue. It will also be important to examine outcomes up to one year postpartum not only for mother, but also infant and family.\",\n          \"Background\\nSickle cell disease is an inherited autosomal recessive blood condition and is one of the most prevalent genetic blood diseases worldwide. Acute chest syndrome is a frequent complication of sickle cell disease, as well as a major cause of morbidity and the greatest single cause of mortality in children with sickle cell disease. Standard treatment may include intravenous hydration, oxygen as treatment for hypoxia, antibiotics to treat the infectious cause and blood transfusions may be given. This is an update of a Cochrane Review first published in 2010 and updated in 2016. \\nObjectives\\nTo assess the effectiveness of blood transfusions, simple and exchange, for treating acute chest syndrome by comparing improvement in symptoms and clinical outcomes against standard care. \\nSearch methods\\nWe searched The Cochrane Cystic Fibrosis and Genetic Disorders Group's Haemoglobinopathies Trials Register, which comprises references identified from comprehensive electronic database searches and handsearching of relevant journals and abstract books of conference proceedings. \\nDate of the most recent search: 30 May 2019.\\nSelection criteria\\nRandomised controlled trials and quasi\\u2010randomised controlled trials comparing either simple or exchange transfusion versus standard care (no transfusion) in people with sickle cell disease suffering from acute chest syndrome. \\nData collection and analysis\\nBoth authors independently selected trials and assessed the risk of bias, no data could be extracted. \\nMain results\\nOne trial was eligible for inclusion in the review. While in the multicentre trial 237 people were enrolled (169 SCC, 42 SC, 15 S\\u03b2\\u2070\\u2010thalassaemia, 11S\\u03b2+\\u2010thalassaemia); the majority were recruited to an observational arm and only ten participants met the inclusion criteria for randomisation. Of these, four were randomised to the transfusion arm and received a single transfusion of 7 to 13 mL/kg packed red blood cells, and six were randomised to standard care. None of the four participants who received packed red blood cells developed acute chest syndrome, while 33% (two participants) developed acute chest syndrome in standard care arm. No data for any pre\\u2010defined outcomes were available. \\nAuthors' conclusions\\nWe found only one very small randomised controlled trial; this is not enough to make any reliable conclusion to support the use of blood transfusion. Whilst there appears to be some indication that chronic blood transfusion may play a roll in reducing the incidence of acute chest syndrome in people with sickle cell disease and albeit offering transfusions may be a widely accepted clinical practice, there is currently no reliable evidence to support or refute the perceived benefits of these as treatment options; very limited information about any of the potential harms associated with these interventions or indeed guidance that can be used to aid clinical decision making. Clinicians should therefore base any treatment decisions on a combination of; their clinical experience, individual circumstances and the unique characteristics and preferences of adequately informed people with sickle cell disease who are suffering with acute chest syndrome. This review highlights the need of further high quality research to provide reliable evidence for the effectiveness of these interventions for the relief of the symptoms of acute chest syndrome in people with sickle cell disease.\",\n          \"Background\\nMyelofibrosis is a bone marrow disorder characterized by excessive production of reticulin and collagen fiber deposition caused by hematological and non\\u2010hematological disorders. The prognosis of myelofibrosis is poor and treatment is mainly palliative. Janus kinase inhibitors are a novel strategy to treat people with myelofibrosis. \\nObjectives\\nTo determine the clinical benefits and harms of Janus kinase\\u20101 and Janus kinase\\u20102 inhibitors for treating myelofibrosis secondary to hematological or non\\u2010hematological conditions. \\nSearch methods\\nWe searched the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library 2014, Issue 11), Ovid MEDLINE (from 1946 to 13 November 2014), EMBASE (from 1980 to 12 January 2013), and LILACS (from 1982 to 20 November 2014). We searched WHO International Clinical Trials Registry Platform and The metaRegister of Controlled Trials. We also searched for conference proceedings of the American Society of Hematology (from 2009 to October 2013), European Hematology Association (from 2009 to October 2013), American Society of Clinical Oncology (from 2009 to October 2013), and European Society of Medical Oncology (from 2009 to October 2013). We included searches in FDA, European Medicines Agency, and Epistemonikos. We handsearched the references of all identified included trials, and relevant review articles. We did not apply any language restrictions. Two review authors independently screened search results. \\nSelection criteria\\nWe included randomized clinical trials comparing Janus kinase\\u20101 and Janus kinase\\u20102 inhibitors with placebo or other treatments. Both previously treated and treatment naive patients were included. \\nData collection and analysis\\nWe used the hazard ratio (HR) and 95% confidence interval (95% CI) for overall survival, progression\\u2010free survival and leukemia\\u2010free survival, risk ratio (RR) and 95% CI for reduction in spleen size and adverse events binary data, and standardized mean differences (SMD) and 95% CI for continuous data (health\\u2010related quality of life). Two review authors independently extracted data and assessed the risk of bias of included trials. Primary outcomes were overall survival, progression\\u2010free survival and adverse events. \\nMain results\\nWe included two trials involving 528 participants, comparing ruxolitinib with placebo or best available therapy (BAT). As the two included trials had different comparators we did not pool the data. The confidence in the results estimates of these trials was low due to the bias in their design, and their limited sample sizes that resulted in imprecise results. \\nThere is low quality evidence for the effect of ruxolitinib on survival when compared with placebo at 51 weeks of follow\\u2010up (HR 0.51, 95% CI 0.27 to 0.98) and compared with BAT at 48 weeks of follow\\u2010up (HR 0.70, 95% CI 0.20 to 2.47). Similarly there was very low quality evidence for the effect of ruxolitinib on progression free survival compared with BAT (HR 0.81, 95% CI 0.47 to 1.39). \\nThere is low quality evidence for the effect of ruxolitinib in terms of quality of life. Compared with placebo, the drug achieved a greater proportion of patients with a significant reduction of symptom scores (RR 8.82, 95% CI 4.40 to 17.69), and treated patients with ruxolitinib obtained greater MFSAF scores at the end of follow\\u2010up (MD \\u201087.90, 95% CI \\u2010139.58 to \\u201036.22). An additional trial showed significant differences in EORTC QLQ\\u2010C30 scores when compared ruxolitinib with best available therapy (MD 7.60, 95% CI 0.35 to 14.85). \\nThe effect of ruxolitinib on reduction in the spleen size of participants compared with placebo or BAT was uncertain (versus placebo: RR 64.58, 95% CI 9.08 to 459.56, low quality evidence; versus BAT: RR 41.78, 95% CI 2.61 to 669.75, low quality evidence). \\nThere is low quality evidence for the effect of the drug compared with placebo on anemia (RR 2.35, 95% CI 1.62 to 3.41), neutropenia (RR 3.57, 95% CI 1.02 to 12.55) and thrombocytopenia (RR 9.74, 95% CI 2.32 to 40.96). Ruxolitinib did not result in differences versus BAT in the risk of anemia (RR 1.35, 95% CI 0.91 to 1.99, low quality evidence) or thrombocytopenia (RR 1.20; 95% CI 0.44 to 3.28, low quality evidence). The risk of non\\u2010hematologic grade 3 or 4 adverse events (including fatigue, arthralgia, nausea, diarrhea, extremity pain and pyrexia) was similar when ruxolitinib was compared with placebo or BAT. The rate of neutropenia comparing ruxolitinib with standard medical treatment was not reported by the trial. \\nAuthors' conclusions\\nCurrently, there is insufficient evidence to allow any conclusions regarding the efficacy and safety of ruxolitinib for treating myelofibrosis. The findings of this Cochrane review should be interpreted with caution as they are based on trials sponsored by industry, and include a small number of patients. Unless powered randomized clinical trials provide strong evidence of a treatment effect, and the trade\\u2010off between potential benefits and harms is established, clinicians should be cautious when administering ruxolitinib for treating patients with myelofibrosis.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 3
        }
      ],
      "source": [
        "import glob, pandas as pd\n",
        "import os\n",
        "import re\n",
        "\n",
        "# NÃºmero mÃ¡ximo de pares\n",
        "pares = 8000\n",
        "\n",
        "pls_files = sorted(glob.glob(\"data_collection_and_processing/Data Sources/Cochrane/train/pls/*.txt\"))\n",
        "non_pls_files = sorted(glob.glob(\"data_collection_and_processing/Data Sources/Cochrane/train/non_pls/*.txt\"))\n",
        "\n",
        "# === Filtrar archivos que contengan 'accumulated' en AMBOS ---\n",
        "pls_files = [f for f in pls_files if \"accumulated\" not in os.path.basename(f).lower()]\n",
        "non_pls_files = [f for f in non_pls_files if \"accumulated\" not in os.path.basename(f).lower()]\n",
        "\n",
        "print(f\"ðŸ“š Total PLS (sin accumulated): {len(pls_files)}\")\n",
        "print(f\"ðŸ“‚ Total non-PLS (sin accumulated): {len(non_pls_files)}\")\n",
        "\n",
        "def extract_id(filename):\n",
        "    base = os.path.basename(filename)\n",
        "    match = re.match(r\"(.+?)\\.pub\\d+\", base)\n",
        "    return match.group(1) if match else base.split(\".txt\")[0]\n",
        "\n",
        "pls_dict = {extract_id(p): p for p in pls_files}\n",
        "non_pls_dict = {extract_id(n): n for n in non_pls_files}\n",
        "\n",
        "data = []\n",
        "for base_id, non_path in non_pls_dict.items():\n",
        "    if base_id in pls_dict:\n",
        "        pls_path = pls_dict[base_id]\n",
        "        with open(pls_path, \"r\", encoding=\"utf-8\") as f1, open(non_path, \"r\", encoding=\"utf-8\") as f2:\n",
        "            data.append({\n",
        "                \"id\": base_id,\n",
        "                \"file_pls\": os.path.basename(pls_path),\n",
        "                \"file_non_pls\": os.path.basename(non_path),\n",
        "                \"pls\": f1.read().strip(),\n",
        "                \"non_pls\": f2.read().strip()\n",
        "            })\n",
        "    if len(data) >= pares:\n",
        "        break\n",
        "\n",
        "df = pd.DataFrame(data)\n",
        "\n",
        "output_path = \"cochrane_pairs_clean.csv\"\n",
        "df.to_csv(output_path, index=False, encoding=\"utf-8\")\n",
        "\n",
        "print(f\"\\nâœ… Emparejados {len(df)} pares por nombre base (sin 'accumulated' en ninguno)\")\n",
        "print(f\"ðŸ’¾ Guardado en: {output_path}\")\n",
        "df.head(3)\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import re\n",
        "from collections import Counter\n",
        "import unicodedata\n",
        "\n",
        "candidate_titles = Counter()\n",
        "\n",
        "for file in pls_files:\n",
        "    with open(file, encoding=\"utf-8\") as f:\n",
        "        lines = f.read().splitlines()\n",
        "\n",
        "    for line in lines:\n",
        "        s = line.strip()\n",
        "\n",
        "        # Detectar si tiene pinta de tÃ­tulo\n",
        "        if (\n",
        "            1 <= len(s.split()) <= 7          # lÃ­neas cortas\n",
        "            and s[0].isupper()               # empieza en mayÃºscula\n",
        "            and not s.endswith(\".\")          # tÃ­tulos NO terminan en punto\n",
        "            and len(s) < 80                  # para evitar pÃ¡rrafos cortos\n",
        "        ):\n",
        "            candidate_titles[s.lower()] += 1\n",
        "\n",
        "print(\"âž¡ï¸ TÃ­tulos detectados (sin normalizar):\")\n",
        "for title, count in candidate_titles.most_common(30):\n",
        "    print(f\"{count} â†’ {title}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MDoxB9LPgI4-",
        "outputId": "3f9e22af-d3ce-46ef-e578-8cf13bb50e97"
      },
      "execution_count": 4,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "âž¡ï¸ TÃ­tulos detectados (sin normalizar):\n",
            "1868 â†’ background\n",
            "1538 â†’ study characteristics\n",
            "1480 â†’ key results\n",
            "1289 â†’ review question\n",
            "1031 â†’ quality of the evidence\n",
            "314 â†’ search date\n",
            "308 â†’ key messages\n",
            "288 â†’ conclusions\n",
            "224 â†’ what is the issue?\n",
            "221 â†’ how upâ€toâ€date is this review?\n",
            "214 â†’ quality of evidence\n",
            "213 â†’ what did we find?\n",
            "203 â†’ what does this mean?\n",
            "199 â†’ certainty of the evidence\n",
            "199 â†’ what did we do?\n",
            "182 â†’ what is the aim of this review?\n",
            "177 â†’ what evidence did we find?\n",
            "177 â†’ what was studied in the review?\n",
            "165 â†’ why is this important?\n",
            "157 â†’ conclusion\n",
            "110 â†’ what did we want to find out?\n",
            "92 â†’ study funding sources\n",
            "88 â†’ what we found\n",
            "84 â†’ results\n",
            "83 â†’ what are the limitations of the evidence?\n",
            "78 â†’ main results\n",
            "65 â†’ key findings\n",
            "62 â†’ how up to date is this evidence?\n",
            "61 â†’ why is this review important?\n",
            "59 â†’ key results and quality of the evidence\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import re\n",
        "import unicodedata\n",
        "from collections import Counter\n",
        "\n",
        "# ------------------------------------------------------\n",
        "# 1) DETECTAR TODOS LOS TÃTULOS EN LOS PLS\n",
        "# ------------------------------------------------------\n",
        "\n",
        "candidate_titles = Counter()\n",
        "\n",
        "for file in pls_files:   # <-- ya filtrados sin \"accumulated\"\n",
        "    with open(file, encoding=\"utf-8\") as f:\n",
        "        lines = f.read().splitlines()\n",
        "\n",
        "    for line in lines:\n",
        "        s = line.strip()\n",
        "\n",
        "        # Regla para detectar tÃ­tulos\n",
        "        if (\n",
        "            1 <= len(s.split()) <= 7          # pocas palabras\n",
        "            and s[0].isupper()               # empieza en mayÃºscula\n",
        "            and not s.endswith(\".\")          # no acaba en punto\n",
        "            and len(s) < 80                  # no demasiado largo\n",
        "        ):\n",
        "            candidate_titles[s.lower()] += 1\n",
        "\n",
        "print(\"\\n=== TÃTULOS DETECTADOS (sin normalizar) ===\")\n",
        "for title, count in candidate_titles.most_common(30):\n",
        "    print(f\"{count} â†’ {title}\")\n",
        "\n",
        "\n",
        "# ------------------------------------------------------\n",
        "# 2) NORMALIZAR TÃTULOS (evitar duplicados)\n",
        "# ------------------------------------------------------\n",
        "\n",
        "def normalize_title(s):\n",
        "    s = s.lower().strip()\n",
        "    s = s.rstrip(\":\")\n",
        "    s = unicodedata.normalize(\"NFKD\", s)\n",
        "    s = s.replace(\"  \", \" \")\n",
        "    return s\n",
        "\n",
        "normalized_counts = Counter()\n",
        "\n",
        "for title, count in candidate_titles.items():\n",
        "    normalized_counts[normalize_title(title)] += count\n",
        "\n",
        "print(\"\\n=== TÃTULOS NORMALIZADOS ===\")\n",
        "for t, c in normalized_counts.most_common(40):\n",
        "    print(f\"{c} â†’ {t}\")\n",
        "\n",
        "\n",
        "# ------------------------------------------------------\n",
        "# 3) PREPARAR LISTA DE TÃTULOS Y REGEX\n",
        "# ------------------------------------------------------\n",
        "\n",
        "SECTION_NAMES = list(normalized_counts.keys())\n",
        "\n",
        "SECTION_REGEX = [\n",
        "    re.compile(rf\"^{re.escape(name)}\\b\", re.IGNORECASE)\n",
        "    for name in SECTION_NAMES\n",
        "]\n",
        "\n",
        "\n",
        "# ------------------------------------------------------\n",
        "# 4) DETECTAR PATRONES DE SECCIONES POR ARCHIVO\n",
        "# ------------------------------------------------------\n",
        "\n",
        "pattern_counts = Counter()\n",
        "\n",
        "for file in pls_files:\n",
        "    with open(file, encoding=\"utf-8\") as f:\n",
        "        lines = f.read().splitlines()\n",
        "\n",
        "    found = []\n",
        "\n",
        "    for line in lines:\n",
        "        clean = normalize_title(line.strip())\n",
        "        for name, reg in zip(SECTION_NAMES, SECTION_REGEX):\n",
        "            if reg.match(clean):\n",
        "                found.append(name)\n",
        "                break\n",
        "\n",
        "    if found:\n",
        "        pattern_counts[tuple(found)] += 1\n",
        "    else:\n",
        "        pattern_counts[(\"NO_TITLES\",)] += 1\n",
        "\n",
        "\n",
        "# ------------------------------------------------------\n",
        "# 5) MOSTRAR LOS PATRONES MÃS COMUNES\n",
        "# ------------------------------------------------------\n",
        "\n",
        "print(\"\\n=== PATRONES DE SECCIONES MÃS FRECUENTES ===\")\n",
        "for pattern, count in pattern_counts.most_common(30):\n",
        "    print(f\"{count} â†’ {pattern}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "YGVKoPjVhT8Y",
        "outputId": "2b57b2e3-5fd5-4d82-da75-3aa154451d5d"
      },
      "execution_count": 5,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "=== TÃTULOS DETECTADOS (sin normalizar) ===\n",
            "1868 â†’ background\n",
            "1538 â†’ study characteristics\n",
            "1480 â†’ key results\n",
            "1289 â†’ review question\n",
            "1031 â†’ quality of the evidence\n",
            "314 â†’ search date\n",
            "308 â†’ key messages\n",
            "288 â†’ conclusions\n",
            "224 â†’ what is the issue?\n",
            "221 â†’ how upâ€toâ€date is this review?\n",
            "214 â†’ quality of evidence\n",
            "213 â†’ what did we find?\n",
            "203 â†’ what does this mean?\n",
            "199 â†’ certainty of the evidence\n",
            "199 â†’ what did we do?\n",
            "182 â†’ what is the aim of this review?\n",
            "177 â†’ what evidence did we find?\n",
            "177 â†’ what was studied in the review?\n",
            "165 â†’ why is this important?\n",
            "157 â†’ conclusion\n",
            "110 â†’ what did we want to find out?\n",
            "92 â†’ study funding sources\n",
            "88 â†’ what we found\n",
            "84 â†’ results\n",
            "83 â†’ what are the limitations of the evidence?\n",
            "78 â†’ main results\n",
            "65 â†’ key findings\n",
            "62 â†’ how up to date is this evidence?\n",
            "61 â†’ why is this review important?\n",
            "59 â†’ key results and quality of the evidence\n",
            "\n",
            "=== TÃTULOS NORMALIZADOS ===\n",
            "1874 â†’ background\n",
            "1543 â†’ study characteristics\n",
            "1485 â†’ key results\n",
            "1294 â†’ review question\n",
            "1036 â†’ quality of the evidence\n",
            "314 â†’ search date\n",
            "312 â†’ key messages\n",
            "289 â†’ conclusions\n",
            "224 â†’ what is the issue?\n",
            "221 â†’ how upâ€toâ€date is this review?\n",
            "216 â†’ quality of evidence\n",
            "213 â†’ what did we find?\n",
            "203 â†’ what does this mean?\n",
            "201 â†’ certainty of the evidence\n",
            "199 â†’ what did we do?\n",
            "182 â†’ what is the aim of this review?\n",
            "177 â†’ what evidence did we find?\n",
            "177 â†’ what was studied in the review?\n",
            "165 â†’ why is this important?\n",
            "157 â†’ conclusion\n",
            "111 â†’ what did we want to find out?\n",
            "92 â†’ study funding sources\n",
            "88 â†’ what we found\n",
            "85 â†’ results\n",
            "83 â†’ what are the limitations of the evidence?\n",
            "79 â†’ main results\n",
            "65 â†’ key findings\n",
            "62 â†’ how up to date is this evidence?\n",
            "61 â†’ why is this review important?\n",
            "60 â†’ key results and quality of the evidence\n",
            "58 â†’ study characteristics and key results\n",
            "57 â†’ how up to date is this review?\n",
            "55 â†’ what was studied in this review?\n",
            "55 â†’ bottom line\n",
            "53 â†’ what should happen next?\n",
            "52 â†’ certainty of evidence\n",
            "48 â†’ which studies were included in the review?\n",
            "45 â†’ what are the implications of this review?\n",
            "40 â†’ who will be interested in this review?\n",
            "40 â†’ methods\n",
            "\n",
            "=== PATRONES DE SECCIONES MÃS FRECUENTES ===\n",
            "863 â†’ ('NO_TITLES',)\n",
            "140 â†’ ('review question', 'background', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "71 â†’ ('what is the issue', 'why is this important', 'what evidence did we find', 'what does this mean')\n",
            "59 â†’ ('we found',)\n",
            "41 â†’ ('review question', 'background', 'study characteristics', 'key results', 'quality of evidence')\n",
            "29 â†’ ('overall',)\n",
            "27 â†’ ('background', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "26 â†’ ('review question', 'background', 'search date', 'the evidence', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "25 â†’ ('what is the aim of this review', 'key messages', 'what was studied in the review', 'how upâ€toâ€date is this review')\n",
            "24 â†’ ('review question', 'background', 'study characteristics', 'the evidence', 'key results', 'quality of the evidence')\n",
            "22 â†’ ('what is the issue', 'conclusions')\n",
            "18 â†’ ('what is the issue', 'why is this important', 'what evidence did we find', 'we found', 'what does this mean')\n",
            "18 â†’ ('what should happen next',)\n",
            "18 â†’ ('review question', 'background', 'study characteristics', 'key results', 'quality of the evidence', 'the evidence')\n",
            "18 â†’ ('background', 'review question', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "17 â†’ ('review question', 'background', 'study characteristics', 'key results')\n",
            "16 â†’ ('review question', 'background', 'study characteristics', 'key results', 'we found', 'quality of the evidence')\n",
            "15 â†’ ('review question', 'background', 'study characteristics', 'we found', 'key results', 'quality of the evidence')\n",
            "15 â†’ ('review question', 'background', 'study characteristics', 'key results', 'certainty of the evidence')\n",
            "14 â†’ ('background', 'study characteristics', 'key results')\n",
            "13 â†’ ('background', 'study characteristics', 'key results', 'we found', 'quality of the evidence')\n",
            "12 â†’ ('the evidence',)\n",
            "12 â†’ ('review question', 'background', 'search date', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "12 â†’ ('in summary',)\n",
            "12 â†’ ('background',)\n",
            "11 â†’ ('what did the researchers investigate',)\n",
            "11 â†’ ('background', 'study characteristics', 'quality of the evidence')\n",
            "11 â†’ ('review question', 'background', 'search date', 'the evidence', 'study characteristics', 'key results')\n",
            "11 â†’ ('what is the issue', 'we found', 'conclusions')\n",
            "11 â†’ ('background', 'study characteristics', 'key results', 'quality of evidence', 'future research')\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "# ================================\n",
        "# Agrupar patrones en 4 macrogrupos\n",
        "# ================================\n",
        "\n",
        "macro_groups = {\n",
        "    \"A_Cochrane_classic\": 0,\n",
        "    \"B_Issue_Important_Evidence\": 0,\n",
        "    \"C_No_titles\": 0,\n",
        "    \"D_Others\": 0\n",
        "}\n",
        "\n",
        "grouped_examples = {k: [] for k in macro_groups.keys()}  # Para guardar ejemplos\n",
        "\n",
        "for pattern, count in pattern_counts.items():\n",
        "\n",
        "    pattern_set = set(pattern)\n",
        "\n",
        "    # --- Grupo C: sin tÃ­tulos ---\n",
        "    if pattern == (\"NO_TITLES\",):\n",
        "        macro_groups[\"C_No_titles\"] += count\n",
        "        grouped_examples[\"C_No_titles\"].append((pattern, count))\n",
        "        continue\n",
        "\n",
        "    # --- Grupo A: estilo Cochrane clÃ¡sico ---\n",
        "    if any(p in pattern_set for p in [\n",
        "        \"review question\",\n",
        "        \"study characteristics\",\n",
        "        \"search date\",\n",
        "        \"key results\",\n",
        "        \"quality of the evidence\",\n",
        "        \"quality of evidence\"\n",
        "    ]):\n",
        "        macro_groups[\"A_Cochrane_classic\"] += count\n",
        "        grouped_examples[\"A_Cochrane_classic\"].append((pattern, count))\n",
        "        continue\n",
        "\n",
        "    # --- Grupo B: estilo narrativo ---\n",
        "    if any(p in pattern_set for p in [\n",
        "        \"what is the issue\",\n",
        "        \"why is this important\",\n",
        "        \"what evidence did we find\",\n",
        "        \"what does this mean\"\n",
        "    ]):\n",
        "        macro_groups[\"B_Issue_Important_Evidence\"] += count\n",
        "        grouped_examples[\"B_Issue_Important_Evidence\"].append((pattern, count))\n",
        "        continue\n",
        "\n",
        "    # --- Grupo D: otros ---\n",
        "    macro_groups[\"D_Others\"] += count\n",
        "    grouped_examples[\"D_Others\"].append((pattern, count))\n",
        "\n",
        "\n",
        "print(\"\\n=== Macro-grupos encontrados ===\")\n",
        "for group, count in macro_groups.items():\n",
        "    print(f\"{group}: {count} PLS\")\n",
        "\n",
        "print(\"\\n=== Ejemplos por grupo ===\")\n",
        "for group, examples in grouped_examples.items():\n",
        "    print(f\"\\n--- {group} ---\")\n",
        "    for p, c in sorted(examples, key=lambda x: -x[1])[:10]:\n",
        "        print(f\"{c} â†’ {p}\")\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "5q8ctNFAh7tm",
        "outputId": "c21b9f0d-7bfa-484f-aa05-2ccd584cce75"
      },
      "execution_count": 6,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "=== Macro-grupos encontrados ===\n",
            "A_Cochrane_classic: 2226 PLS\n",
            "B_Issue_Important_Evidence: 281 PLS\n",
            "C_No_titles: 863 PLS\n",
            "D_Others: 1427 PLS\n",
            "\n",
            "=== Ejemplos por grupo ===\n",
            "\n",
            "--- A_Cochrane_classic ---\n",
            "140 â†’ ('review question', 'background', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "41 â†’ ('review question', 'background', 'study characteristics', 'key results', 'quality of evidence')\n",
            "27 â†’ ('background', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "26 â†’ ('review question', 'background', 'search date', 'the evidence', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "24 â†’ ('review question', 'background', 'study characteristics', 'the evidence', 'key results', 'quality of the evidence')\n",
            "18 â†’ ('review question', 'background', 'study characteristics', 'key results', 'quality of the evidence', 'the evidence')\n",
            "18 â†’ ('background', 'review question', 'study characteristics', 'key results', 'quality of the evidence')\n",
            "17 â†’ ('review question', 'background', 'study characteristics', 'key results')\n",
            "16 â†’ ('review question', 'background', 'study characteristics', 'key results', 'we found', 'quality of the evidence')\n",
            "15 â†’ ('review question', 'background', 'study characteristics', 'we found', 'key results', 'quality of the evidence')\n",
            "\n",
            "--- B_Issue_Important_Evidence ---\n",
            "71 â†’ ('what is the issue', 'why is this important', 'what evidence did we find', 'what does this mean')\n",
            "22 â†’ ('what is the issue', 'conclusions')\n",
            "18 â†’ ('what is the issue', 'why is this important', 'what evidence did we find', 'we found', 'what does this mean')\n",
            "11 â†’ ('what is the issue', 'we found', 'conclusions')\n",
            "5 â†’ ('what is the issue', 'what evidence did we find', 'what does this mean')\n",
            "3 â†’ ('what is the issue', 'why is this important', 'what evidence did we find', 'what does this mean', 'overall')\n",
            "3 â†’ ('what is the issue', 'we asked', 'we found', 'this means')\n",
            "3 â†’ ('what is the issue', 'why is this important', 'what evidence did we find', 'what does this mean', 'we found')\n",
            "3 â†’ ('the issue', 'what does this mean')\n",
            "2 â†’ ('what is the issue', 'we found', 'conclusions', 'we found')\n",
            "\n",
            "--- C_No_titles ---\n",
            "863 â†’ ('NO_TITLES',)\n",
            "\n",
            "--- D_Others ---\n",
            "59 â†’ ('we found',)\n",
            "29 â†’ ('overall',)\n",
            "25 â†’ ('what is the aim of this review', 'key messages', 'what was studied in the review', 'how upâ€toâ€date is this review')\n",
            "18 â†’ ('what should happen next',)\n",
            "12 â†’ ('the evidence',)\n",
            "12 â†’ ('in summary',)\n",
            "12 â†’ ('background',)\n",
            "11 â†’ ('what did the researchers investigate',)\n",
            "8 â†’ ('what is the aim of this review', 'key messages', 'what was studied in this review', 'how upâ€toâ€date is this review')\n",
            "7 â†’ ('the results',)\n"
          ]
        }
      ]
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}